Coverage
-
August 04, 2015
One week after Teva Pharmaceutical Industries Ltd. abandoned its hostile bid for Mylan NV to instead snap up a unit of Allergan plc for $40.5 billion, Mylan and Kirkland & Ellis LLP agreed Tuesday to drop a contentious legal battle in which Mylan sought to disqualify Kirkland as Teva's legal counsel.
10 other articles on this case.
View all »